Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Keda Pharmaceutical Co., Ltd., commonly known as Keda Pharmaceutical, is a pharmaceutical manufacturing company based in Hefei, China. Originally established as an enterprise under the University of Science and Technology of China (USTC), it is now a subsidiary of Anhui Fengyuan Pharmaceutical. The company focuses on the production of chemical drugs across several therapeutic areas, including neurology, cardiology, and anti-infectives. Its core product portfolio features brain metabolism enhancers like Oxiracetam, alongside various injectable and oral formulations. The company maintains multiple GMP-certified production lines and serves as a significant manufacturing hub within its parent group. It is recognized for its integration of academic research roots with large-scale industrial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keda GMP Pharmaceutical Factory.